Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

709
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
709
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

812
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
812
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

591
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
591
Hypertension I: Introduction01:28

Hypertension I: Introduction

1.2K
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
1.2K
Peptic Ulcer01:27

Peptic Ulcer

6
Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the...
6
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

1.4K
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

C-POEM as a therapeutic approach for cricopharyngeal achalasia.

Revista espanola de enfermedades digestivas·2026
Same author

Genetic variants associated with clinical characteristics and atopies in eosinophilic esophagitis.

The journal of allergy and clinical immunology. Global·2026
Same author

Dupilumab for Eosinophilic Esophagitis in Adolescents and Adults: Real-World Outcomes Across Different Dosing Regimens from the EoE CONNECT Registry.

The American journal of gastroenterology·2026
Same author

Prevalence and incidence of chronic kidney disease in patients with primary biliary cholangitis.

Journal of gastroenterology·2026
Same author

Low biopsy rate and PPI use: two persistent barriers in the diagnosis of eosinophilic esophagitis.

Revista espanola de enfermedades digestivas·2026
Same author

Characterization of gastroesophageal reflux disease after peroral endoscopic myotomy: interpreting acid exposure time in the context of pH-impedance patterns.

Revista espanola de enfermedades digestivas·2026

Related Experiment Video

Updated: Mar 21, 2026

Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats
09:37

Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats

Published on: August 1, 2018

15.6K

Portal hypertensive polyps, a new entity?

Verónica Martín Domínguez1, Ariel Díaz Méndez2, Cecilio Santander3

  • 1Aparato Digestivo, Hospital Universitario de la Princesa, España.

Revista Espanola De Enfermedades Digestivas
|May 19, 2016
PubMed
Summary

A case study identified "portal hypertensive polyps" (PHP) in a patient with liver cirrhosis and portal hypertension. These gastric polyps are linked to elevated pressure in the portal vein system.

More Related Videos

Author Spotlight: A Reproductive Hysteroscopy Approach for Complete Endometrial Polyp Removal and Enhanced Endometrial Receptivity
03:01

Author Spotlight: A Reproductive Hysteroscopy Approach for Complete Endometrial Polyp Removal and Enhanced Endometrial Receptivity

Published on: August 2, 2024

2.3K
Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy
07:10

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy

Published on: June 18, 2020

23.3K

Related Experiment Videos

Last Updated: Mar 21, 2026

Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats
09:37

Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats

Published on: August 1, 2018

15.6K
Author Spotlight: A Reproductive Hysteroscopy Approach for Complete Endometrial Polyp Removal and Enhanced Endometrial Receptivity
03:01

Author Spotlight: A Reproductive Hysteroscopy Approach for Complete Endometrial Polyp Removal and Enhanced Endometrial Receptivity

Published on: August 2, 2024

2.3K
Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy
07:10

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy

Published on: June 18, 2020

23.3K

Area of Science:

  • Gastroenterology
  • Hepatology
  • Pathology

Background:

  • Liver cirrhosis, often caused by autoimmune hepatitis, can lead to portal hypertension and coagulopathy.
  • Portal hypertension is a significant complication of advanced liver disease, affecting various organs.
  • Gastric manifestations of portal hypertension are increasingly recognized.

Observation:

  • A 62-year-old woman with a history of autoimmune hepatitis-induced liver cirrhosis presented with symptoms related to portal hypertension.
  • Gastroscopy revealed polypoid and polylobed lesions in the gastric antrum.
  • These lesions were successfully removed for further examination.

Findings:

  • Pathological examination of the gastric lesions identified them as hyperplastic polyps.
  • Histological features included edema, vascular congestion, and smooth muscle hyperplasia.
  • The findings were consistent with the diagnosis of "portal hypertensive polyps" (PHP).

Implications:

  • This case highlights the association between portal hypertension and the development of specific gastric polyps.
  • Recognizing portal hypertensive polyps is crucial for accurate diagnosis and management in cirrhotic patients.
  • Further research may elucidate the precise mechanisms and clinical significance of PHP.